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This single-center, case-control study documents a
relative increase in methicillin resistance among 48 cases
of Staphylococcus aureus–associated postpartum mastitis
during 1998–2005. Of 21 cases with methicillin resistance,
17 (81%) occurred in 2005. Twenty (95%) isolates con-
tained the Staphylococcus cassette chromosome mec
type IV gene; this suggests that the increase is due to
community-acquired methicillin-resistant S.aureus.
P
ostpartum mastitis (PPM) occurs in as many as one
third of breastfeeding women in the United States and
leads to breast abscess formation in ≈10% of cases (1,2).
Although breast milk cultures are not routine in PPM man-
agement, the growth of potentially pathogenic bacteria
(such as β-hemolytic streptococci or Staphylococcus
aureus) is associated with longer time to recovery and
more frequent abscess formation (3). S. aureus is the most
common bacterium isolated from such cultures, represent-
ing 37%–50% of isolates (4,5).
Reports of methicillin-resistant S. aureus (MRSA)
PPM among young, healthy women lacking traditional risk
factors for MRSAhave emerged in the past few years (6,7).
Isolates in these cases of community-acquired infection
(CA-MRSA) remain susceptible to multiple non–β-lactam
antibiotics and possess distinct molecular features (8).
Although risk factors associated with skin and soft tis-
sue infections due to CA-MRSA have been described
(8,9), characteristics unique to patients with CA-MRSA
PPM are unknown. To identify risk factors, complications,
and outcomes among patients with CA-MRSA PPM, we
conducted a retrospective, case-control study to include all
S. aureus–associated cases at a single institution over an 8-
year period. MRSA isolates were analyzed by PCR for the
presence of the Staphylococcus cassette chromosome
(SCC) mec type IV gene, which is commonly associated
with community-acquired infection.
The Study
We considered for analysis all patients from
Northwestern University’s Prentice Women’s Hospital and
affiliated Lynn Sage Comprehensive Breast Center with
wound, fluid, drainage, or breast milk cultures positive for
S. aureus from January 1998 through December 2005.
Case-patients were defined as patients with PPM and a
corresponding culture positive for MRSA. Control-
patients were defined as patients with PPM and a corre-
sponding culture positive for methicillin-susceptible S.
aureus (MSSA). Patients who had no evidence of mastitis
or who had a history of MRSA were excluded from the
study. SCCmec types I–V were identified by a PCR-based
multiplex assay; rapid bacterial DNA extraction and PCR
amplification were performed as described elsewhere (10).
Forty-eight cases of S. aureus–associated PPM were
identified during the study period; 21 cases were due to
MRSA and 27 cases were due to MSSA. A relative
increase in MRSA PPM was noted in the later years of the
study (Figure 1, p = 0.04). MRSA and MSSA patients did
not differ significantly with respect to age, pregnancy his-
tory, or symptoms at the time of initial evaluation. In addi-
tion, MRSA and MSSA patients did not differ in terms of
potential risk factors for infection, such as diabetes, group
B β-hemolytic streptococcus colonization, artificial rup-
ture of membranes, epidural anesthesia, vaginal lacera-
tions, episiotomy, cesarean section, or intrapartum
antibiotic use (Table).
Ten (48%) MRSA and 11 (41%) MSSA patients
required hospitalization. Although these inpatients did not
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Figure 1. Cases of Staphylococcus aureus–associated postpartum
mastitis at a single institution, 1998–2005. Cochrane-Armitage test
for linear trend suggests a relative increase in methicillin-resistant
cases during the study period; p = 0.04.differ in duration of symptoms before admission, length of
stay, or leukocyte count, MRSA patients were more likely
to have fever. One patient in each group required readmis-
sion for recurrent symptoms (Table).
Forty-six study patients had an abscess associated
with mastitis; most (39 patients) underwent needle aspira-
tion. Of these patients, 7 (41%) MRSAand 5 (23%) MSSA
patients required repeat aspiration. Notably, 9 MSSA
patients underwent incision and drainage a median of 4.5
days after aspiration (range 0–17 days), whereas only 1
MRSA patient required subsequent débridement (1 day
later). Reasons for this difference are not clear; however,
the more frequent use of serial ultrasound-guided aspira-
tion in breast abscess management in recent years (when
most MRSA cases occurred) may account for this finding.
In 17 of 21 MRSAcases, antibiotic use was document-
ed. Twelve patients received antibiotics effective against
MRSA, but only 2 received effective coverage at therapy
onset (both received clindamycin). Patients initially
received a penicillinase-resistant penicillin (10 patients), a
first-generation cephalosporin (3 patients), a β-lactam/β-
lactamase inhibitor (1 patient), or some combination of the
above (6 patients). Median time to effective coverage for
MRSAwas 5 days (range 0–16 days); adequate antimicro-
bial agents included vancomycin (4 patients), trimetho-
prim-sulfamethoxazole (1 patient), clindamycin (9
patients), rifampin (2 patients), or some combination of the
above (4 patients). Median duration of therapy, document-
ed in 8 of 12 effective regimens, was 19 days (range 14–62
days).
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MSSA cases; in all 18 cases, isolates were susceptible to
the initial antibiotic of choice. Initial regimens included
penicillinase-resistant penicillins (10 patients), first-gener-
ation cephalosporins (2 patients), macrolides (1 patient),
tetracyclines (1 patient), β-lactam/β-lactamase inhibitors
(1 patient), vancomycin (1 patient), and clindamycin (2
patients). Duration of therapy for MSSA PPM, document-
ed in 12 of 18 cases, was a median of 13.5 days (range
9–27 days).
Medical record review of affected patients did not
show transmission of S. aureus to infants or other family
members. In 1 MRSA patient, a perirectal abscess devel-
oped 5 months after the mastitis resolved. Intraoperative
cultures of the abscess grew MRSA with identical suscep-
tibilities, which suggests persistent colonization; however,
typing of the isolates was not performed.
Of 21 MRSA isolates available for PCR analysis, 20
possessed SCCmec IV. The remaining isolate contained
SCCmec II (Figure 2) and displayed resistance to clin-
damycin. In contrast, 95% of isolates with SCC mec IV
were clindamycin susceptible.
Conclusions
To our knowledge, this is the largest case-control study
of patients with MRSA-associated PPM. Although S.
aureus is the most common etiologic agent of PPM, cases
caused by MRSA have rarely been described. Epidemic
MRSA cases, linked to the hospital transmission of a com-
munity-acquired isolate, have been observed more recently
(6). Our study suggests that CA-MRSA is an increasingly
common pathogen in spontaneous cases of PPM.
PPM due to CA-MRSAappears to be increasing at our
institution. Among 17 MRSA-infected mothers in 2005,
delivery dates spanned >9 months without overlap, which
suggests that MRSA was independently acquired rather
than outbreak-related. In addition, although isolates were
not subjected to molecular typing by pulsed-field gel elec-
trophoresis, PCR results suggest that 16 (94%) of MRSA
isolates in 2005 were community-acquired.
The epidemiology of CA-MRSA PPM is poorly
understood. Notably, nearly twice as many MRSA-infect-
ed than MSSA-infected women were multiparous in this
study (57% vs. 33%, respectively). The prevalence of CA-
MRSA is increasing among young children, and intrafa-
milial transmission of isolates has been documented
(11,12). Therefore, mothers with young children may be at
increased risk for CA-MRSA PPM. Alternatively, these
patients may serve as a reservoir for MRSAin the commu-
nity, transmitting this organism to family members.
In the current study, women with MRSA were signifi-
cantly less likely to receive adequate and timely antimicro-
bial drug treatment, but consequences of this difference are
unclear. Lee et al. suggest that small CA-MRSA abscesses
in children can be managed effectively with incision and
drainage alone (13). Indeed, most women in this study
underwent incision and drainage or wound aspiration with-
out significant differences in outcomes. Although MSSA
patients were more likely to undergo breast abscess incision
and drainage than their MRSA counterparts, both methods
are considered appropriate surgical interventions (14).
Although related cases of infant infection were not
found, charts of household contacts were not reviewed in
this study; cases of S. aureus transmission to infants or
other family members may have been undetected. Several
authors have reported mother-to-infant transmission of
MRSA through breast milk (15,16). Although decoloniza-
tion measures in MRSA-colonized patients have not
demonstrated long-term effectiveness (17), the possibility
of infant MRSA acquisition may warrant further evalua-
tion of such measures in infected, breastfeeding mothers.
As with any retrospective case-control study, ours had
several limitations. First, the study population is small,
which limits the generalizability of the results. Second,
patients were added to the study by using results of posi-
tive cultures; consequently, cases likely represented more
severe and complicated infections in which cultures were
necessary after routine therapeutic measures failed. Third,
although PPM has been associated with multiple patient
factors (i.e., difficulty breastfeeding, tobacco use, and
stress), a thorough risk assessment is limited by retrospec-
tive study. In addition, medical record review may not
indicate certain CA-MRSA risk factors, such as socioeco-
nomic status, history of incarceration, or exposure to day
care facilities. Finally, although the study results suggest a
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Figure 2. A) PCR with specific primers for class B mec complex (1.3
kb) and type 2 ccr complex (1.0 kb) identifies isolates containing
Staphylococcus cassette chromosome (SCC) mec type IV: lanes 1,
2, and 4-7. B) When control strains are used, PCR identifies
SCCmec type II in isolate 3. Lane M, molecular mass markerrecent increase in MRSAPPM, an assessment of incidence
would require further prospective analysis.
In summary, CA-MRSA has emerged as an increas-
ingly common pathogen in PPM. Therapy against CA-
MRSA should be considered in refractory or severe cases
of PPM until wound, drainage, or breast milk cultures can
be obtained. Adjunct surgical drainage or aspiration is
often warranted in such cases. Additional study is required
to determine the utility of routine cultures in postpartum
mastitis, the prevalence of CA-MRSA in this emerging
problem, and the consequences of CA-MRSAcolonization
for breastfeeding infants.
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